1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Geographic Atrophy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Above 60 Years
        1.2.3 Above 75 Years
    1.3 Market by Application
        1.3.1 Global Geographic Atrophy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Late-stage (Phase III)
        1.3.3 Phase II
        1.3.4 Phase I
        1.3.5 Pre-clinical stage
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Geographic Atrophy Market Perspective (2017-2028)
    2.2 Geographic Atrophy Growth Trends by Region
        2.2.1 Geographic Atrophy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Geographic Atrophy Historic Market Size by Region (2017-2022)
        2.2.3 Geographic Atrophy Forecasted Market Size by Region (2023-2028)
    2.3 Geographic Atrophy Market Dynamics
        2.3.1 Geographic Atrophy Industry Trends
        2.3.2 Geographic Atrophy Market Drivers
        2.3.3 Geographic Atrophy Market Challenges
        2.3.4 Geographic Atrophy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Geographic Atrophy Players by Revenue
        3.1.1 Global Top Geographic Atrophy Players by Revenue (2017-2022)
        3.1.2 Global Geographic Atrophy Revenue Market Share by Players (2017-2022)
    3.2 Global Geographic Atrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Geographic Atrophy Revenue
    3.4 Global Geographic Atrophy Market Concentration Ratio
        3.4.1 Global Geographic Atrophy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Revenue in 2021
    3.5 Geographic Atrophy Key Players Head office and Area Served
    3.6 Key Players Geographic Atrophy Product Solution and Service
    3.7 Date of Enter into Geographic Atrophy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Geographic Atrophy Breakdown Data by Type
    4.1 Global Geographic Atrophy Historic Market Size by Type (2017-2022)
    4.2 Global Geographic Atrophy Forecasted Market Size by Type (2023-2028)
5 Geographic Atrophy Breakdown Data by Application
    5.1 Global Geographic Atrophy Historic Market Size by Application (2017-2022)
    5.2 Global Geographic Atrophy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Geographic Atrophy Market Size (2017-2028)
    6.2 North America Geographic Atrophy Market Size by Country (2017-2022)
    6.3 North America Geographic Atrophy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Geographic Atrophy Market Size (2017-2028)
    7.2 Europe Geographic Atrophy Market Size by Country (2017-2022)
    7.3 Europe Geographic Atrophy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Geographic Atrophy Market Size (2017-2028)
    8.2 Asia-Pacific Geographic Atrophy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Geographic Atrophy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Geographic Atrophy Market Size (2017-2028)
    9.2 Latin America Geographic Atrophy Market Size by Country (2017-2022)
    9.3 Latin America Geographic Atrophy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Geographic Atrophy Market Size (2017-2028)
    10.2 Middle East & Africa Geographic Atrophy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Geographic Atrophy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Apellis Pharmaceuticals
        11.1.1 Apellis Pharmaceuticals Company Detail
        11.1.2 Apellis Pharmaceuticals Business Overview
        11.1.3 Apellis Pharmaceuticals Geographic Atrophy Introduction
        11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Business (2017-2022)
        11.1.5 Apellis Pharmaceuticals Recent Development
    11.2 Iveric Bio
        11.2.1 Iveric Bio Company Detail
        11.2.2 Iveric Bio Business Overview
        11.2.3 Iveric Bio Geographic Atrophy Introduction
        11.2.4 Iveric Bio Revenue in Geographic Atrophy Business (2017-2022)
        11.2.5 Iveric Bio Recent Development
    11.3 Alkeus Pharmaceuticals
        11.3.1 Alkeus Pharmaceuticals Company Detail
        11.3.2 Alkeus Pharmaceuticals Business Overview
        11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Introduction
        11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Business (2017-2022)
        11.3.5 Alkeus Pharmaceuticals Recent Development
    11.4 Hemera Biosciences
        11.4.1 Hemera Biosciences Company Detail
        11.4.2 Hemera Biosciences Business Overview
        11.4.3 Hemera Biosciences Geographic Atrophy Introduction
        11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Business (2017-2022)
        11.4.5 Hemera Biosciences Recent Development
    11.5 Allegro Ophthalmics
        11.5.1 Allegro Ophthalmics Company Detail
        11.5.2 Allegro Ophthalmics Business Overview
        11.5.3 Allegro Ophthalmics Geographic Atrophy Introduction
        11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Business (2017-2022)
        11.5.5 Allegro Ophthalmics Recent Development
    11.6 Stealth BioTherapeutics
        11.6.1 Stealth BioTherapeutics Company Detail
        11.6.2 Stealth BioTherapeutics Business Overview
        11.6.3 Stealth BioTherapeutics Geographic Atrophy Introduction
        11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Business (2017-2022)
        11.6.5 Stealth BioTherapeutics Recent Development
    11.7 Gyroscope Therapeutics
        11.7.1 Gyroscope Therapeutics Company Detail
        11.7.2 Gyroscope Therapeutics Business Overview
        11.7.3 Gyroscope Therapeutics Geographic Atrophy Introduction
        11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Business (2017-2022)
        11.7.5 Gyroscope Therapeutics Recent Development
    11.8 Regenerative Patch Technologies
        11.8.1 Regenerative Patch Technologies Company Detail
        11.8.2 Regenerative Patch Technologies Business Overview
        11.8.3 Regenerative Patch Technologies Geographic Atrophy Introduction
        11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Business (2017-2022)
        11.8.5 Regenerative Patch Technologies Recent Development
    11.9 Roche
        11.9.1 Roche Company Detail
        11.9.2 Roche Business Overview
        11.9.3 Roche Geographic Atrophy Introduction
        11.9.4 Roche Revenue in Geographic Atrophy Business (2017-2022)
        11.9.5 Roche Recent Development
    11.10 Gensight Biologics
        11.10.1 Gensight Biologics Company Detail
        11.10.2 Gensight Biologics Business Overview
        11.10.3 Gensight Biologics Geographic Atrophy Introduction
        11.10.4 Gensight Biologics Revenue in Geographic Atrophy Business (2017-2022)
        11.10.5 Gensight Biologics Recent Development
    11.11 NGM Biopharmaceuticals
        11.11.1 NGM Biopharmaceuticals Company Detail
        11.11.2 NGM Biopharmaceuticals Business Overview
        11.11.3 NGM Biopharmaceuticals Geographic Atrophy Introduction
        11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Business (2017-2022)
        11.11.5 NGM Biopharmaceuticals Recent Development
    11.12 AstraZeneca
        11.12.1 AstraZeneca Company Detail
        11.12.2 AstraZeneca Business Overview
        11.12.3 AstraZeneca Geographic Atrophy Introduction
        11.12.4 AstraZeneca Revenue in Geographic Atrophy Business (2017-2022)
        11.12.5 AstraZeneca Recent Development
    11.13 Lineage Cell Therapeutics
        11.13.1 Lineage Cell Therapeutics Company Detail
        11.13.2 Lineage Cell Therapeutics Business Overview
        11.13.3 Lineage Cell Therapeutics Geographic Atrophy Introduction
        11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Business (2017-2022)
        11.13.5 Lineage Cell Therapeutics Recent Development
    11.14 Allergan
        11.14.1 Allergan Company Detail
        11.14.2 Allergan Business Overview
        11.14.3 Allergan Geographic Atrophy Introduction
        11.14.4 Allergan Revenue in Geographic Atrophy Business (2017-2022)
        11.14.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Geographic Atrophy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Above 60 Years
    Table 3. Key Players of Above 75 Years
    Table 4. Global Geographic Atrophy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Geographic Atrophy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Geographic Atrophy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Geographic Atrophy Market Share by Region (2017-2022)
    Table 8. Global Geographic Atrophy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Geographic Atrophy Market Share by Region (2023-2028)
    Table 10. Geographic Atrophy Market Trends
    Table 11. Geographic Atrophy Market Drivers
    Table 12. Geographic Atrophy Market Challenges
    Table 13. Geographic Atrophy Market Restraints
    Table 14. Global Geographic Atrophy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Geographic Atrophy Market Share by Players (2017-2022)
    Table 16. Global Top Geographic Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy as of 2021)
    Table 17. Ranking of Global Top Geographic Atrophy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Geographic Atrophy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Geographic Atrophy Product Solution and Service
    Table 21. Date of Enter into Geographic Atrophy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Geographic Atrophy Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Geographic Atrophy Revenue Market Share by Type (2017-2022)
    Table 25. Global Geographic Atrophy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Geographic Atrophy Revenue Market Share by Type (2023-2028)
    Table 27. Global Geographic Atrophy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Geographic Atrophy Revenue Market Share by Application (2017-2022)
    Table 29. Global Geographic Atrophy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Geographic Atrophy Revenue Market Share by Application (2023-2028)
    Table 31. North America Geographic Atrophy Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Geographic Atrophy Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Geographic Atrophy Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Geographic Atrophy Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Geographic Atrophy Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Geographic Atrophy Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Geographic Atrophy Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Geographic Atrophy Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Geographic Atrophy Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Geographic Atrophy Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Apellis Pharmaceuticals Company Detail
    Table 42. Apellis Pharmaceuticals Business Overview
    Table 43. Apellis Pharmaceuticals Geographic Atrophy Product
    Table 44. Apellis Pharmaceuticals Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 45. Apellis Pharmaceuticals Recent Development
    Table 46. Iveric Bio Company Detail
    Table 47. Iveric Bio Business Overview
    Table 48. Iveric Bio Geographic Atrophy Product
    Table 49. Iveric Bio Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 50. Iveric Bio Recent Development
    Table 51. Alkeus Pharmaceuticals Company Detail
    Table 52. Alkeus Pharmaceuticals Business Overview
    Table 53. Alkeus Pharmaceuticals Geographic Atrophy Product
    Table 54. Alkeus Pharmaceuticals Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 55. Alkeus Pharmaceuticals Recent Development
    Table 56. Hemera Biosciences Company Detail
    Table 57. Hemera Biosciences Business Overview
    Table 58. Hemera Biosciences Geographic Atrophy Product
    Table 59. Hemera Biosciences Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 60. Hemera Biosciences Recent Development
    Table 61. Allegro Ophthalmics Company Detail
    Table 62. Allegro Ophthalmics Business Overview
    Table 63. Allegro Ophthalmics Geographic Atrophy Product
    Table 64. Allegro Ophthalmics Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 65. Allegro Ophthalmics Recent Development
    Table 66. Stealth BioTherapeutics Company Detail
    Table 67. Stealth BioTherapeutics Business Overview
    Table 68. Stealth BioTherapeutics Geographic Atrophy Product
    Table 69. Stealth BioTherapeutics Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 70. Stealth BioTherapeutics Recent Development
    Table 71. Gyroscope Therapeutics Company Detail
    Table 72. Gyroscope Therapeutics Business Overview
    Table 73. Gyroscope Therapeutics Geographic Atrophy Product
    Table 74. Gyroscope Therapeutics Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 75. Gyroscope Therapeutics Recent Development
    Table 76. Regenerative Patch Technologies Company Detail
    Table 77. Regenerative Patch Technologies Business Overview
    Table 78. Regenerative Patch Technologies Geographic Atrophy Product
    Table 79. Regenerative Patch Technologies Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 80. Regenerative Patch Technologies Recent Development
    Table 81. Roche Company Detail
    Table 82. Roche Business Overview
    Table 83. Roche Geographic Atrophy Product
    Table 84. Roche Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 85. Roche Recent Development
    Table 86. Gensight Biologics Company Detail
    Table 87. Gensight Biologics Business Overview
    Table 88. Gensight Biologics Geographic Atrophy Product
    Table 89. Gensight Biologics Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 90. Gensight Biologics Recent Development
    Table 91. NGM Biopharmaceuticals Company Detail
    Table 92. NGM Biopharmaceuticals Business Overview
    Table 93. NGM Biopharmaceuticals Geographic AtrophyProduct
    Table 94. NGM Biopharmaceuticals Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 95. NGM Biopharmaceuticals Recent Development
    Table 96. AstraZeneca Company Detail
    Table 97. AstraZeneca Business Overview
    Table 98. AstraZeneca Geographic AtrophyProduct
    Table 99. AstraZeneca Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 100. AstraZeneca Recent Development
    Table 101. Lineage Cell Therapeutics Company Detail
    Table 102. Lineage Cell Therapeutics Business Overview
    Table 103. Lineage Cell Therapeutics Geographic AtrophyProduct
    Table 104. Lineage Cell Therapeutics Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 105. Lineage Cell Therapeutics Recent Development
    Table 106. Allergan Company Detail
    Table 107. Allergan Business Overview
    Table 108. Allergan Geographic AtrophyProduct
    Table 109. Allergan Revenue in Geographic Atrophy Business (2017-2022) & (US$ Million)
    Table 110. Allergan Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Geographic Atrophy Market Share by Type: 2021 VS 2028
    Figure 2. Above 60 Years Features
    Figure 3. Above 75 Years Features
    Figure 4. Global Geographic Atrophy Market Share by Application in 2021 & 2028
    Figure 5. Late-stage (Phase III) Case Studies
    Figure 6. Phase II Case Studies
    Figure 7. Phase I Case Studies
    Figure 8. Pre-clinical stage Case Studies
    Figure 9. Geographic Atrophy Report Years Considered
    Figure 10. Global Geographic Atrophy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Geographic Atrophy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Geographic Atrophy Market Share by Region: 2021 VS 2028
    Figure 13. Global Geographic Atrophy Market Share by Players in 2021
    Figure 14. Global Top Geographic Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Geographic Atrophy Revenue in 2021
    Figure 16. North America Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Geographic Atrophy Market Share by Country (2017-2028)
    Figure 18. United States Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Geographic Atrophy Market Share by Country (2017-2028)
    Figure 22. Germany Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Geographic Atrophy Market Share by Region (2017-2028)
    Figure 30. China Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Geographic Atrophy Market Share by Country (2017-2028)
    Figure 38. Mexico Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Geographic Atrophy Market Share by Country (2017-2028)
    Figure 42. Turkey Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Geographic Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Apellis Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 45. Iveric Bio Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 46. Alkeus Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 47. Hemera Biosciences Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 48. Allegro Ophthalmics Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 49. Stealth BioTherapeutics Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 50. Gyroscope Therapeutics Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 51. Regenerative Patch Technologies Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 52. Roche Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 53. Gensight Biologics Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 54. NGM Biopharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 55. AstraZeneca Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 56. Lineage Cell Therapeutics Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 57. Allergan Revenue Growth Rate in Geographic Atrophy Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed